According to recent study titled ‘Cardiac Rhythm Management (CRM) Devices Market Share, Size, Trends & Industry Analysis By Product, By Regions: Segment Forecast 2019-2026’, available with Market Study Report, global cardiac rhythm management (CRM) devices market is projected to expand at a CAGR of 7.5% during 2019-2026, subsequently accounting USD 35.22 billion by the end of the forecast period.
 

According to industry experts, rising burden of cardiovascular devices, favorable legislative policies by governments, and positive reimbursement scenarios are the major growth drivers of global cardiac rhythm management (CRM) devices market. Moreover, technological advancements such as emergence of implantable cardioverter-defibrillators integrated with pacemakers has positively impacted the industry outlook.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2963754/
 

Based on product type, global cardiac rhythm management (CRM) devices market is categorized into pacemakers, defribilators, and cardiac resynchronization therapy (CRT). The pacemakers segment is further split into implantable pacemakers and external pacemakers. Likewise, defibrillators segment is divided into implantable cardioverter defibrillators (ICDs), and external defibrillator (ED).
 

Global cardiac rhythm management (CRM) device market from external defibrillator segment is likely to grow substantially during the forecast period. Upsurge in the cases of sudden cardiac arrest (SCA) is driving the segment growth.
 

Considering the geographical scope, the key regions considered in global cardiac rhythm management (CRM) devices market report are North America (United States, Canada), Europe (Germany, France, UK), Asia Pacific (India, China, Japan), Latin America (Brazil), and Middle East & Africa.
 

Reliable sources cite that North America secured nearly 35% of global cardiac rhythm management (CRM) devices market share in 2019. Supportive government policies, favorable reimbursement schemes, and high number of patients with CVDs are fostering the regional market expansion. Meanwhile, Asia Pacific market is projected to showcase a yearly growth rate of 9% over the stipulated timeframe, owing to growing accessibility of CRM devices in the region.
 

Key players that hold a majority stake in global cardiac rhythm management (CRM) devices market are Abbot Laboratories, Schiller AG, Medtronic plc, LivaNova plc, Koninklijke Philips N.V., Hill-Rom Holdings, Inc., General Electric Company, Cardiac Science Corp., Boston Scientific Corp., Biotronik SE & Co., KG, Berlin Heart GmbH, and Abiomed, Inc.